1887

Abstract

A recent study reported the detection of a bat-derived virus (BatPV/Epo_spe/AR1/DCR/2009, batMuV) with phylogenetic relatedness to human mumps virus (hMuV). Since all efforts to isolate infectious batMuV have reportedly failed, we generated recombinant mumps viruses (rMuVs) in which the open reading frames (ORFs) of the fusion (F) and haemagglutinin-neuraminidase (HN) glycoproteins of an hMuV strain were replaced by the corresponding ORFs of batMuV. The batMuV F and HN proteins were successfully incorporated into viral particles and the resultant chimeric virus was able to mediate infection of Vero cells. Distinct differences were observed between the fusogenicity of rMuVs expressing one or both batMuV glycoproteins: viruses expressing batMuV F were highly fusogenic, regardless of the origin of HN. In contrast, rMuVs expressing human F and bat-derived HN proteins were less fusogenic compared to hMuV. The growth kinetics of chimeric MuVs expressing batMuV HN in combination with either hMuV or batMuV F were similar to that of the backbone virus, whereas a delay in virus replication was obtained for rMuVs harbouring batMuV F and hMuV HN. Replacement of the hMuV F and HN genes or the HN gene alone by the corresponding batMuV genes led to a slight reduction in neurovirulence of the highly neurovirulent backbone strain. Neutralizing antibodies inhibited infection mediated by all recombinant viruses generated. Furthermore, group IV anti-MuV antibodies inhibited the neuraminidase activity of bat-derived HN. Our study reports the successful generation of chimeric MuVs expressing the F and HN proteins of batMuV, providing a means for further examination of this novel batMuV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000596
2016-11-10
2019-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/11/2837.html?itemId=/content/journal/jgv/10.1099/jgv.0.000596&mimeType=html&fmt=ahah

References

  1. Aguilar H. C., Matreyek K. A., Filone C. M., Hashimi S. T., Levroney E. L., Negrete O. A., Bertolotti-Ciarlet A., Choi D. Y., McHardy I. et al.( 2006;). N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. . J Virol80:4878–4889. [CrossRef][PubMed]
    [Google Scholar]
  2. Amexis G., Rubin S., Chatterjee N., Carbone K., Chumakov K..( 2003;). Identification of a new genotype H wild-type mumps virus strain and its molecular relatedness to other virulent and attenuated strains. . J Med Virol70:284–286. [CrossRef][PubMed]
    [Google Scholar]
  3. Bagai S., Lamb R. A..( 1995;). Individual roles of N-linked oligosaccharide chains in intracellular transport of the paramyxovirus SV5 fusion protein. . Virology209:250–256. [CrossRef][PubMed]
    [Google Scholar]
  4. Beard C. M., Benson R. C., Kelalis P. P., Elveback L. R., Kurland L. T..( 1977;). The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974. . Mayo Clin Proc52:3–7.[PubMed]
    [Google Scholar]
  5. Brostrom M. A., Bruening G., Bankowski R. A..( 1971;). Comparison of neuraminidases of paramyxoviruses with immunologically dissimilar hemagglutinins. . Virology46:856–865. [CrossRef][PubMed]
    [Google Scholar]
  6. Buchholz U. J., Finke S., Conzelmann K. K..( 1999;). Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. . J Virol73:251–259.[PubMed]
    [Google Scholar]
  7. Calain P., Roux L..( 1993;). The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. . J Virol67:4822–4830.[PubMed]
    [Google Scholar]
  8. Cdc.( 2015;). Mumps. . In Epidemiology and Prevention of Vaccine-Preventable Diseases: The Pink Book: Course Textbook. 13. Edited by Hamborsky J., Kroger A., Wolfe C.. Washington, DC:: Public Health Foundation;.
    [Google Scholar]
  9. Chang A., Dutch R. E..( 2012;). Paramyxovirus fusion and entry: multiple paths to a common end. . Viruses4:613–636. [CrossRef][PubMed]
    [Google Scholar]
  10. Cox R., Green T. J., Purushotham S., Deivanayagam C., Bedwell G. J., Prevelige P. E., Luo M..( 2013;). Structural and functional characterization of the mumps virus phosphoprotein. . J Virol87:7558–7568. [CrossRef][PubMed]
    [Google Scholar]
  11. Drexler J. F., Corman V. M., Müller M. A., Maganga G. D., Vallo P., Binger T., Gloza-Rausch F., Cottontail V. M., Rasche A. et al.( 2012;). Bats host major mammalian paramyxoviruses. . Nat Commun3:796. [CrossRef][PubMed]
    [Google Scholar]
  12. Elango N., Varsanyi T. M., Kövamees J., Norrby E..( 1988;). Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. . J Gen Virol69:2893–2900. [CrossRef][PubMed]
    [Google Scholar]
  13. Gale M. Jr., Tan S. L., Katze M. G..( 2000;). Translational control of viral gene expression in eukaryotes. . Microbiol Mol Biol Rev64:239–280. [CrossRef][PubMed]
    [Google Scholar]
  14. Hausmann S., Jacques J. P., Kolakofsky D..( 1996;). Paramyxovirus RNA editing and the requirement for hexamer genome length. . RNA2:1033–1045.[PubMed]
    [Google Scholar]
  15. Hoffmann M., Wu Y. J., Gerber M., Berger-Rentsch M., Heimrich B., Schwemmle M., Zimmer G..( 2010;). Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity. . J Gen Virol91:2782–2793. [CrossRef][PubMed]
    [Google Scholar]
  16. Hosaka Y., Kuroda K., Ikeura A., Iwamoto T., Suzuki Y..( 1998;). Binding of influenza and paramyxoviruses to group B streptococcus with the terminal sialyl-galactose linkage. . J Electron Microsc47:169–174. [CrossRef]
    [Google Scholar]
  17. Katoh H., Kubota T., Ihara T., Maeda K., Takeda M., Kidokoro M..( 2016;). Cross-neutralization between human and African bat mumps viruses. . Emerg Infect Dis22:703–706. [CrossRef][PubMed]
    [Google Scholar]
  18. Kolakofsky D., Roux L., Garcin D., Ruigrok R. W..( 2005;). Paramyxovirus mRNA editing, the ‘rule of six’ and error catastrophe: a hypothesis. . J Gen Virol86:1869–1877. [CrossRef][PubMed]
    [Google Scholar]
  19. Kövamees J., Rydbeck R., Orvell C., Norrby E..( 1990;). Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. . Virus Res17:119–129. [CrossRef][PubMed]
    [Google Scholar]
  20. Krüger N., Hoffmann M., Drexler J. F., Müller M. A., Corman V. M., Sauder C., Rubin S., He B., Örvell C. et al.( 2015;). Functional properties and genetic relatedness of the fusion and hemagglutinin-neuraminidase proteins of a mumps virus-like bat virus. . J Virol89:4539–4548. [CrossRef][PubMed]
    [Google Scholar]
  21. Leprat R., Aymard M..( 1979;). Selective inactivation of hemagglutinin and neuraminidase on mumps virus. . Arch Virol61:273–281. [CrossRef][PubMed]
    [Google Scholar]
  22. Malik T., Sauder C., Wolbert C., Zhang C., Carbone K. M., Rubin S..( 2007a;). A single nucleotide change in the mumps virus F gene affects virus fusogenicity in vitro and virulence in vivo. . J Neurovirol13:513–521. [CrossRef]
    [Google Scholar]
  23. Malik T., Wolbert C., Mauldin J., Sauder C., Carbone K. M., Rubin S. A..( 2007b;). Functional consequences of attenuating mutations in the haemagglutinin neuraminidase, fusion and polymerase proteins of a wild-type mumps virus strain. . J Gen Virol88:2533–2541. [CrossRef]
    [Google Scholar]
  24. McCarthy M., Johnson R. T..( 1980;). A comparison of the structural polypeptides of five strains of mumps virus. . J Gen Virol46:15–27. [CrossRef][PubMed]
    [Google Scholar]
  25. McGinnes L., Sergel T., Reitter J., Morrison T..( 2001;). Carbohydrate modifications of the NDV fusion protein heptad repeat domains influence maturation and fusion activity. . Virology283:332–342. [CrossRef][PubMed]
    [Google Scholar]
  26. Merz D. C., Wolinsky J. S..( 1981;). Biochemical features of mumps virus neuraminidases and their relationship with pathogenicity. . Virology114:218–227. [CrossRef][PubMed]
    [Google Scholar]
  27. Merz D. C., Server A. C., Waxham M. N., Wolinsky J. S..( 1983;). Biosynthesis of mumps virus F glycoprotein: non-fusing strains efficiently cleave the F glycoprotein precursor. . J Gen Virol64:1457–1467. [CrossRef][PubMed]
    [Google Scholar]
  28. Orvell C..( 1984;). The reactions of monoclonal antibodies with structural proteins of mumps virus. . J Immunol132:2622–2629.[PubMed]
    [Google Scholar]
  29. Orvell C., Alsheikhly A. R., Kalantari M., Johansson B..( 1997;). Characterization of genotype-specific epitopes of the HN protein of mumps virus. . J Gen Virol78:3187–3193. [CrossRef][PubMed]
    [Google Scholar]
  30. Orvell C., Tecle T., Johansson B., Saito H., Samuelson A..( 2002;). Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus. . J Gen Virol83:2489–2496. [CrossRef][PubMed]
    [Google Scholar]
  31. Paterson R. G., Lamb R. A..( 1990;). RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. . J Virol64:4137–4145.[PubMed]
    [Google Scholar]
  32. Rubin S., Beeler J..( 2013;). Mumps vaccines: do we need a new one?. Pediatr Infect Dis J32:1156–1157. [CrossRef][PubMed]
    [Google Scholar]
  33. Rubin S. A., Pletnikov M., Taffs R., Snoy P. J., Kobasa D., Brown E. G., Wright K. E., Carbone K. M..( 2000;). Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. . J Virol74:5382–5384. [CrossRef][PubMed]
    [Google Scholar]
  34. Russell R. R., Donald J. C..( 1958;). The neurological complications of mumps. . Br Med J2:27–30. [CrossRef][PubMed]
    [Google Scholar]
  35. Samal S. K..( 2011;). The Biology of Paramyxoviruses. Norfolk, UK:: Caister Academic Press;.
    [Google Scholar]
  36. Santos-López G., Scior T., Borraz-Argüello M. T., Vallejo-Ruiz V., Herrera-Camacho I., Tapia-Ramírez J., Reyes-Leyva J..( 2009;). Structure-function analysis of two variants of mumps virus hemagglutinin-neuraminidase protein. . Braz J Infect Dis13:24–34. [CrossRef]
    [Google Scholar]
  37. Sauder C. J., Zhang C. X., Ngo L., Werner K., Lemon K., Duprex W. P., Malik T., Carbone K., Rubin S. A..( 2011;). Gene-specific contributions to mumps virus neurovirulence and neuroattenuation. . J Virol85:7059–7069. [CrossRef][PubMed]
    [Google Scholar]
  38. Sauder C. J., Ngo L., Simonyan V., Cong Y., Zhang C., Link M., Malik T., Rubin S. A..( 2015;). Generation and propagation of recombinant mumps viruses exhibiting an additional U residue in the homopolymeric U tract of the F gene-end signal. . Virus Genes51:12–24. [CrossRef][PubMed]
    [Google Scholar]
  39. Server A. C., Merz D. C., Waxham M. N., Wolinsky J. S..( 1982;). Differentiation of mumps virus strains with monoclonal antibody to the HN glycoprotein. . Infect Immun35:179–186.[PubMed]
    [Google Scholar]
  40. Sidhu M. S., Menonna J. P., Cook S. D., Dowling P. C., Udem S. A..( 1993;). Canine distemper virus L gene: sequence and comparison with related viruses. . Virology193:50–65. [CrossRef][PubMed]
    [Google Scholar]
  41. Takeuchi K., Tanabayashi K., Hishiyama M., Yamada A..( 1996;). The mumps virus SH protein is a membrane protein and not essential for virus growth. . Virology225:156–162. [CrossRef][PubMed]
    [Google Scholar]
  42. Tanabayashi K., Takeuchi K., Okazaki K., Hishiyama M., Yamada A..( 1993;). Identification of an amino acid that defines the fusogenicity of mumps virus. . J Virol67:2928–2931.[PubMed]
    [Google Scholar]
  43. von Messling V., Cattaneo R..( 2003;). N-linked glycans with similar location in the fusion protein head modulate paramyxovirus fusion. . J Virol77:10202–10212. [CrossRef][PubMed]
    [Google Scholar]
  44. Wolinsky J. S., Stroop W. G..( 1978;). Virulence and persistence of three prototype strains of mumps virus in newborn hamsters. . Arch Virol57:355–359. [CrossRef][PubMed]
    [Google Scholar]
  45. Yoshida N., Nakayama T..( 2010;). Leucine at position 383 of fusion protein is responsible for fusogenicity of wild-type mumps virus in B95a cells. . Intervirology53:193–202. [CrossRef][PubMed]
    [Google Scholar]
  46. Zimmer G., Trotz I., Herrler G..( 2001;). N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus. . J Virol75:4744–4751. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000596
Loading
/content/journal/jgv/10.1099/jgv.0.000596
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error